| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/21/2008 | US20080200441 Estrogen receptor modulators associated pharmaceutical compositions and methods of use |
| 08/21/2008 | US20080200440 Progesterone receptor antagonists |
| 08/21/2008 | US20080200439 Establishing a test sample comprising a myocyte BK channel beta 1 subunit and measuring the interaction, effect, or combination thereof, of a candidate composition on test sample to thereby determine ability of candidate composition to modulate myocyte BK channel activity |
| 08/21/2008 | US20080200438 such as multiple sclerosis, neuritis, amylotrophic lateral sclerosis; use of aminoalcohols or phosphate derivatives thereof, such as 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-propane-1,3-diol or phosphoric acid mono-2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-propyl]ester |
| 08/21/2008 | US20080200437 Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases |
| 08/21/2008 | US20080200436 Antiangiogenic and/or vascular permeability reducing effect; cancer, solid tumors; kits |
| 08/21/2008 | US20080200435 Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
| 08/21/2008 | US20080200434 Chemical Target-Binding Compositions |
| 08/21/2008 | US20080200433 Molecular Chaperone Function Regulator |
| 08/21/2008 | US20080200432 Fiber-Treating Agent |
| 08/21/2008 | US20080200431 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa |
| 08/21/2008 | US20080200430 Repairing vocal chords with chitin and/or chitosan particles; bioresorbable fibrosis stimulating fillers with intermediate lifetimes; avoiding chronic inflammatory reactions and/or rejection |
| 08/21/2008 | US20080200429 Purified Beta Glucan Composition |
| 08/21/2008 | US20080200428 Antiproliferative Drug |
| 08/21/2008 | US20080200427 Protecting fur bearing animals from skin adhesion of microorganisms; ointment containing such as rhamnose, galactose and mannose; dermatitis, keratoseborrheic syndrome, external otitis, pyoderma |
| 08/21/2008 | US20080200426 Use of Chondroitin Sulphate E (Cs-E) for the Treatment of Diseases or Conditions Related to Collagen Fibril Formation |
| 08/21/2008 | US20080200424 Preparation for Treating Cancer |
| 08/21/2008 | US20080200423 Novel Tricyclic Nucleosides or Nucleotides as Therapeutic Agents |
| 08/21/2008 | US20080200422 Methods for reduction of adipose tissue mass |
| 08/21/2008 | US20080200421 Heparin linked to bioabsorbable polylactone; restenosis prevention; stent implants; synthesis |
| 08/21/2008 | US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 08/21/2008 | US20080200418 Compositions for drug administration |
| 08/21/2008 | US20080200417 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 08/21/2008 | US20080200416 Modulation of T cell signaling threshold and T cell sensitivity to antigens |
| 08/21/2008 | US20080200415 Plant Activation of Insect Toxin |
| 08/21/2008 | US20080200414 HCaRG, A Novel Calcium-Regulated Gene |
| 08/21/2008 | US20080200413 Oligonucleotide sequences which bind biomolecules such as peptides; selectively bind coagulation factors, E2F family members, Ang1 or Ang2; hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals |
| 08/21/2008 | US20080200412 Astrocyte Elevated Gene-1 And Its Promoter In Treatments For Neurotoxicity And Malignancy |
| 08/21/2008 | US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder |
| 08/21/2008 | US20080200409 Binds to and modifies splicing of dystrophin gene; muscular dystrophy |
| 08/21/2008 | US20080200408 Isolated recombinant nucleic acids; expression constructs; stably transformed or transfected host cells; sodium channel antagonistic analgesic agents; side effect reduction |
| 08/21/2008 | US20080200406 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| 08/21/2008 | US20080200405 Drug Resistance Reversal In Neoplastic Disease |
| 08/21/2008 | US20080200404 Therapeutic, prophylactic treatment of drug-resistant malarial strain; resistant to chloroquine, mefloquine, halofantrine, artemisinin, atovaquone/proguanil, doxycycline, primaquine |
| 08/21/2008 | US20080200403 Semi-synthetic 9a-carbamoyl or thiocarbamoyl azalides; use of 15-membered azalides having at the 9a-position a carbamoyl or thiocarbamoyl group; inhibitor of TNF- alpha , IL-1, IL-6, IL-8, IL-2 or IL-5; and inhibitor of excessive lymphocyte proliferation; and excessive granulocyte degranulation |
| 08/21/2008 | US20080200402 Use Of Fumagillin And The Derivatives Thereof To Increase The Bioavilability Of The Macrocyclic Lactones |
| 08/21/2008 | US20080200401 Mixing powdered oleander leaf with supercritical carbon dioxide above critical pressure and critical temperature; depressurization and cooling to give a separated extract mixture; recovering cardiac glycoside-containing extract which acts as an antiproliferative agent; solvent extraction |
| 08/21/2008 | US20080200387 Anti-angiogenic protein, composition and use thereof |
| 08/21/2008 | US20080200382 Inhibiting of the proliferation of tumor cells is mediated by upregulation of the activity of p53 |
| 08/21/2008 | US20080200376 Compositions and Methods For the Treatment Of Obesity and Sexual Dysfunction |
| 08/21/2008 | US20080200372 Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions |
| 08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 08/21/2008 | US20080200370 Method of treating drug addiction using dextro-morphine |
| 08/21/2008 | US20080200369 Inhibiting bystin mediated arrest and promoting autophosphorylation of epidermal growth factor receptor; sperm motility, embryonic stem cell formation, trophoblast formation, neuronal growth |
| 08/21/2008 | US20080199957 therapeutic or diagnostic agent is covalently coupled to the transport agent, which is poly(2-ethylacrylic acid), poly(2-propylacrylic acid), poly(2-butylacrylic acid); drug delivery of proteins, DNA, nucleotides through endosomal membrane |
| 08/21/2008 | US20080199896 Using inhibitors of target of rapamycin (TOR) gene products as therapeutic agent in treatment of cardiovascular disorders |
| 08/21/2008 | US20080199550 Novel Anticancer Agent, Methods for Obtaining the Same and Pharmaceutical Compositions Thereof |
| 08/21/2008 | US20080199548 Purified fruit and berry extract; cyclooxygenase inhibitor; oxidation resistance |
| 08/21/2008 | US20080199547 Berry Oils and Products |
| 08/21/2008 | US20080199546 Bone growth mixture of quercetin and plant extracts of licorice, ginsengwith bone morphogenic protein gene expression |
| 08/21/2008 | US20080199543 Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith |
| 08/21/2008 | US20080199542 Use of Winter Savory (Satureja Montana) or the Extracts Thereof For the Preparation of Medicaments For the Treatment of the Premature Ejaculation |
| 08/21/2008 | US20080199538 Using herbal supplements; mixture of plant extracts, phenylalanine, niacinamide , seeds and lavender |
| 08/21/2008 | US20080199534 Mixture containing metal compound and oxidizable vitamin; stabilization |
| 08/21/2008 | US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures |
| 08/21/2008 | US20080199529 Nanoparticle delivery vehicle |
| 08/21/2008 | US20080199527 sustained release; coated with polymer |
| 08/21/2008 | US20080199522 Timed-release compression-coated solid composition for oral administration |
| 08/21/2008 | US20080199520 Cognition activators; antiaging agent;veterinary medicine |
| 08/21/2008 | US20080199518 Using 5-fluoro-8-94-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; sustained release bead; core containing drug and multilayer overcoatings; cognition activators; anxiolytic agents; Parkinson's, Huntington's, Alzheimer's disease; psychological disorders |
| 08/21/2008 | US20080199517 Composition and a process thereof |
| 08/21/2008 | US20080199515 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders |
| 08/21/2008 | US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy |
| 08/21/2008 | US20080199512 Oral Composition For Moisturizing Skin |
| 08/21/2008 | US20080199511 Sustained Release Compositions Containing Progesterone Receptor Modulators |
| 08/21/2008 | US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides |
| 08/21/2008 | US20080199494 Vaccine |
| 08/21/2008 | US20080199487 Such as (2S,3S,4R)-1-O-( alpha -D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol; kits |
| 08/21/2008 | US20080199485 Method for enhancing T cell response |
| 08/21/2008 | US20080199484 Using cyclooxgenase inhibitor as antitumor therapeutic in treatment of cell proliferative disorders |
| 08/21/2008 | US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199468 Method For Diagnosing Colorectal Cancers |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199464 Combination Therapy with Angiogenesis Inhibitors |
| 08/21/2008 | US20080199462 Preventing airway mucus production by administration of egf-r antagonists |
| 08/21/2008 | US20080199459 Mitotic Kinesin Inhibitors |
| 08/21/2008 | US20080199458 Therapeutic mixture comprising St. john's wort and preferential immunoglobulins for use in treatment of viral infections |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
| 08/21/2008 | US20080199449 Methods and Compositions for Use in Treating Vascular Diseases and Conditions |
| 08/21/2008 | US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 08/21/2008 | US20080199444 Administering Bacillus, Clostridium, or Bifidobacterium and oligosaccharide; Irritable bowel syndrome or diarrhea which starts after eating cold or raw food or drinking alcohol |
| 08/21/2008 | US20080199443 Bone Morphogenetic Variants, Compositions and Methods of Treatment |
| 08/21/2008 | US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin |
| 08/21/2008 | US20080199438 Methods For Suppressing Tumor Proliferation |
| 08/21/2008 | US20080199435 IL-8 Like Protein |
| 08/21/2008 | US20080199434 Compositions and methods for the treatment of cardiovascular conditions |
| 08/21/2008 | US20080199428 Administering deferasirox, 4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid, interferon and ribavirin; hepatitis and non-alcoholic steatohepatitis |
| 08/21/2008 | US20080199427 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C |
| 08/21/2008 | US20080199426 Administering compound which inhibits tie-1 protein, thrombin, growth factors; increases activity of nitric oxide synthase; arteriosclerosis, sepsis, rheumatoid arthritis and pre-eclampsia |
| 08/21/2008 | US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide |
| 08/21/2008 | US20080199422 Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline |
| 08/21/2008 | US20080199421 W/o emulsion |
| 08/21/2008 | US20080199414 Tiliroside or derivative; drugs, foods; ultraviolet radiation filters; aging and oxidation resistance; free radical scavengers; antiinflammatory, anticarcinogenic, and antiallergen agents; plant extracts; topically applied |
| 08/21/2008 | US20080199413 Novel Use of Organic Compounds |
| 08/21/2008 | US20080199407 Drug Detoxification Protocol Using Microdosing |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | US20080199400 Otologic nanotechnology |